Acute Coronary Syndrome

Clinical Recognition, Diagnostic Evaluation, and Emergency Cardiac Management

Introduction

Acute Coronary Syndrome (ACS) is caused by a sudden reduction in blood flow to the myocardium. It is one of the leading causes of mortality around the world, accounting for approximately 32% of deaths annually. In ACS, early recognition and prompt treatment are critical because myocardial injury can happen within minutes of coronary artery occlusion. This paper reviews the clinical recognition, diagnostic evaluation, and emergency cardiac management of Acute Coronary Syndrome.

Pathophysiology

Frequently, the development of ACS starts with coronary artery disease. Coronary arteries supply oxygen-rich blood to the myocardium, which is the muscular tissue of the heart. Over many years, fatty deposits (known as atherosclerotic plaques) build up inside these arteries. This process, called atherosclerosis, gradually narrows the arterial lumen and reduces blood flow.

Atherosclerotic plaques differ in their stability. While some remain stable for years, others become vulnerable to rupture. When a vulnerable plaque ruptures, its contents are exposed to circulating blood. The body interprets this rupture as a vascular injury and immediately activates platelets, which stick to the ruptured plaque and clump together. Simultaneously, clotting factors activate, forming a blood clot that may partially or completely block blood flow through the coronary artery. The severity of the blockage determines the type of ACS.

When blood flow through the coronary artery is reduced, the myocardium doesn’t receive enough oxygen and nutrients to function properly. This lack of oxygen, which is called myocardial ischemia, makes the heart unable to pump efficiently. This causes waste to build up in the affected tissue, often causing chest pain.

If blood flow isn’t restored quickly, the ischemic myocardium begins to suffer irreversible damage. Heart cells start dying; this process is known as myocardial infarction. The amount of damage depends on how long the blockage lasts and the size of the affected coronary artery. As more myocardial tissue is damaged, the heart’s pumping effectiveness decreases.

The three types of acute coronary syndrome depend on how blocked a heart blood vessel is. When a blood vessel is completely blocked for a long time, the heart doesn’t get enough blood and oxygen, causing an ST-elevation MI (STEMI), which is a serious type of heart attack. When the blockage is only partial, however, it can cause non-ST-elevation MI (or NSTEMI). If the blockage damages heart muscle, a protein called troponin will leak into the blood stream and show high levels on a blood test. If there is no sign of heart muscle damage on a blood test, the condition is called unstable angina.

Clinical Recognition

Early recognition of ACS is important because delays in treatment can lead to increased myocardial damage. The most common symptom is chest pain, which is often described as pressure or heaviness in the chest. The pain may spread to other areas of the body, including the neck, jaw, shoulders, back, or arms, especially the left arm.

In addition to chest pain, patients may experience shortness of breath, sweating, nausea, vomiting, dizziness, fatigue, or palpitations. However, symptoms do not always present in the same way. Women, older adults, and patients with diabetes are more likely to experience atypical symptoms, like fatigue, weakness, or nausea, rather than significant chest pain.

Diagnostic Evaluation

Rapid diagnosis of ACS is critical. ACS is a medical emergency, and diagnosis is based on the combination of the patient’s symptoms, physical examination findings, electrocardiogram (ECG), blood tests that can detect heart damage, and other diagnostic tests if necessary.

The first step in the evaluation process includes obtaining a thorough patient history. It is important to assess the characteristics of the patient's chest pain, including when it started, how long it has been present, where it is located, and whether it radiates to other areas like the jaw, neck, back, or arms. Other symptoms (shortness of breath, sweating, nausea, vomiting, dizziness, fatigue, and palpitations) should also be assessed. Also, providers should identify risk factors that increase the likelihood of coronary artery disease, such as high blood pressure, diabetes, high cholesterol, smoking, and obesity.

A physical examination is performed to assess the patient's overall condition and identify signs that may indicate complications of ACS. Vital signs like blood pressure, heart rate, respiratory rate, oxygen saturation, and temperature should be obtained. Patients may present with tachycardia, hypotension, or signs of poor perfusion if significant myocardial damage has occurred. Healthcare providers should also assess for signs of heart failure, including pulmonary crackles, jugular venous distention, and peripheral edema.

One of the most important tests for ACS is an ECG, which records the heart’s electrical activity. It can help doctors see if the heart’s not getting enough blood or if a part of the heart has been damaged. In people having a STEMI, a serious type of heart attack, the ECG often shows specific changes that can indicate a completely blocked heart artery. Other people may have different ECG changes that can also suggest that the heart is not getting enough blood. Because these changes may not appear immediately, doctors may repeat the ECG if symptoms persist. An ECG should be done within 10 minutes of the patient first receiving medical care.

Cardiac biomarkers are another important part of diagnosing ACS. Troponin is a substance found in the blood that can show if the heart muscle has been damaged. When the heart is injured, troponin is released into the bloodstream. High troponin levels can help doctors confirm a heart attack and tell the difference between an NSTEMI and unstable angina. Since troponin levels may not rise immediately, doctors usually take multiple blood samples over several hours to monitor for changes.

Coronary angiography is often performed in patients with confirmed or highly suspected ACS. During this procedure, a special dye is injected into the heart’s blood vessels so doctors can see if there are any narrowed or blocked areas. This helps doctors determine the best treatment. If a blockage is found, doctors may also perform a procedure called PCI, which can involve placing a small tube called a stent to open the blocked blood vessel and restore blood flow to the heart.

Emergency Cardiac Management

The main goal of emergency cardiac management in ACS is to restore blood flow to the heart as quickly as possible. Because the heart begins to suffer irreversible injury within a short period of time after blood flow is reduced, rapid treatment is essential. This is why management often begins as soon as ACS is suspected, even before all diagnostic tests have been completed.

The first priority is stabilizing the patient. Healthcare providers assess the patient’s airway, breathing, and circulation while continuously monitoring cardiac rhythm and vital signs. Intravenous access is established so medications can be administered quickly if needed. Oxygen may be given to patients who are experiencing low oxygen levels (below 90%) or respiratory distress, although it is not routinely required for all patients with ACS. Close monitoring allows providers to quickly identify complications such as dangerous arrhythmias, worsening ischemia, or signs of cardiogenic shock.

Several medications are commonly used during the initial treatment of ACS. Aspirin is typically administered as soon as possible because it helps prevent platelets from clumping together and forming larger blood clots. Additional antiplatelet medications may also be given to further reduce clot formation. Anticoagulants are frequently used to prevent existing clots from growing and to decrease the risk of new clot development. Nitroglycerin can help relieve chest pain and improve blood flow by dilating blood vessels and reducing the workload of the heart. Persistent chest pain is treated by addressing ongoing myocardial ischemia; opioid analgesia may be considered selectively when severe pain persists despite other therapies.

For patients experiencing STEMI, restoring blood flow to the affected coronary artery is the highest priority. The preferred treatment is percutaneous coronary intervention. During this procedure, a catheter is guided through an artery (typically the femoral or radial artery)to the blocked coronary artery, where a small balloon is inflated to reopen the vessel. In most cases, a stent is then placed to help keep the artery open and maintain blood flow. PCI has become the preferred reperfusion strategy because it is highly effective at quickly restoring circulation to the myocardium and reducing the extent of permanent heart damage. For optimal cardiac outcomes, a patient should have a door-to-balloon time less than 90 minutes (or less than 120 minutes if transferring hospitals for PCI.

If PCI cannot be performed, fibrinolytic therapy may be used instead. These medications work by dissolving the blood clot that is blocking the coronary artery and restoring blood flow to the heart. Fibrinolytic therapy is most effective when given as early as possible after symptom onset, but it is not appropriate for all patients because it carries a risk of serious bleeding. For example, in a patient with a prior history of a large GI bleed or hemorrhagic stroke, fibrinolytic therapy must be used with extreme caution.

Patients diagnosed with NSTEMI or unstable angina are usually managed differently. Because these conditions usually involve partial rather than complete coronary artery blockage, treatment usually uses medications like antiplatelet agents, anticoagulants, and statins. Patients are carefully assessed to determine their risk of future cardiac events and whether they would benefit from early coronary angiography or PCI. This helps prevent progression of myocardial injury while reducing the likelihood of future complications.

Conclusion

Acute Coronary Syndrome is a serious cardiovascular emergency that requires rapid recognition and treatment. The condition most commonly develops as a result of atherosclerotic plaque rupture and thrombus formation, which reduces blood flow to the myocardium and can lead to myocardial infarction if not treated promptly. Recognizing the signs and symptoms of ACS, including both typical and atypical presentations, is essential for early intervention and improved patient outcomes.

Accurate diagnosis relies on a combination of patient history, physical examination, electrocardiographic findings, cardiac biomarkers, and coronary angiography when indicated. Once ACS is identified, immediate management focuses on preventing further clot formation and restoring coronary blood flow. Treatments like antiplatelet therapy, anticoagulation, percutaneous coronary intervention, and fibrinolytic therapy play a critical role in reducing myocardial damage.

Because ACS remains a leading cause of mortality worldwide, doctors must be prepared to recognize and manage the condition quickly and effectively. Through fast diagnosis, evidence-based treatment, and long-term risk factor management, the impact of ACS can be significantly reduced.

Written by Rupsha Sarkar

Edited by Yasmina Sirgi, MD

References

1. American Heart Association. “Acute Coronary Syndrome.” Www.heart.org, 10 Dec. 2024, www.heart.org/en/health-topics/heart-attack/about-heart-attacks/acute-coronary-syndrome.

2. Blazar, Eric. “Acute Coronary Syndromes.” Default, Sept. 2019, www.saem.org/about-saem/academies-interest-groups-affiliates2/cdem/for-students/online-education/m4-curriculum/group-m4-cardiovascular/acute-coronary-syndromes.

3. Cleveland Clinic. “Acute Coronary Syndrome (ACS): Causes, Symptoms & Treatment.” Cleveland Clinic, 2022, my.clevelandclinic.org/health/diseases/22910-acute-coronary-syndrome.

4. Mayo Clinic. “Acute Coronary Syndrome - Symptoms and Causes.” Mayo Clinic, 16 May 2023, www.mayoclinic.org/diseases-conditions/acute-coronary-syndrome/symptoms-causes/syc-20352136.

5. Raman Nohria, and Anthony J Viera. “Acute Coronary Syndrome: Diagnosis and Initial Management.” American Family Physician, vol. 109, no. 1, 15 Jan. 2024, pp. 34–42, www.aafp.org/afp/2024/0100/acute-coronary-syndrome.

6. Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025.